|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation expense | |||||
| Depreciation and amortization | |||||
| Non-cash lease expense | |||||
| Non-cash interest expense | |||||
| Amortization of premium on investments, net | |||||
| Change in provision for inventories | |||||
| Change in provision for credit losses | |||||
| Other non-cash items | |||||
| Loss on disposal of property and equipment | |||||
| Loss on extinguishment of term loan | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued compensation and related benefits | |||||
| Accrued expenses and other current liabilities | |||||
| Accrued warranty liability | |||||
| Deferred revenue | |||||
| Operating lease liabilities | |||||
| Accrued interest | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Purchases of investment securities | |||||
| Sales and maturities of investment securities | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from stock option exercises and ESPP purchases | |||||
| Proceeds from issuance of term loans, net of issuance costs | |||||
| Repayment of term loan and extinguishment costs | |||||
| Proceeds from issuance of Series A convertible preferred stock, net of issuance costs | |||||
| Payment of deferred financing costs | |||||
| Net cash provided by financing activities | |||||
| Net (decrease) increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash as of beginning of period | |||||
| Cash, cash equivalents and restricted cash as of end of period | |||||
| Summary of cash, cash equivalents and restricted cash reported within the balance sheets: | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
| Total cash, cash equivalents and restricted cash | |||||
| Supplemental cash flow disclosures: | |||||
| Cash paid for income taxes | |||||
| Cash paid for interest | |||||
| Cash paid for amounts included in the measurement of operating lease liabilities | |||||
| Supplemental non-cash investing and financing activities: | |||||
| Transfer of inventories to property and equipment | |||||
| Right-of-use assets obtained in exchange for operating lease liabilities | |||||
| Deferred offering costs included in accrued expenses | |||||
| Fair value of common stock warrant | |||||
| Issuance costs included in accrued expenses | |||||
| Capital expenditures included in accounts payable and accrued expenses | |||||
| Transfer of property and equipment to inventories | |||||
Loading...